Curis | CRIS - Interest Expense On Debt


Curis reported $178K in Interest Expense on Debt for its fiscal quarter ending in December of 2023.





Interest Expense On Debt Change Date
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Amgen USD 653M 94.99B Sep/2026
AstraZeneca USD 371M 31M Sep/2026
Bayer EUR 675M 87M Dec/2025
Bristol-Myers Squibb USD 403M 4M Sep/2026
CSL USD 215M 111M Dec/2025
Curis USD 178K 441K Dec/2023
Eli Lilly USD 316M 201.3M Sep/2026
Exelixis USD 23.4M 3.9M Sep/2023
Gilead Sciences USD 269M 22M Sep/2026
GlaxoSmithKline GBP 219M 98M Sep/2026
Incyte USD 605K 23K Sep/2026
Merck USD 525M 46M Jun/2026
Novartis USD 468M 6M Sep/2026
Pfizer USD 662M 5M Sep/2026
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 222M 65M Sep/2026
Takeda JPY 63.38B 466M Sep/2026
TG Therapeutics USD 16.57M 8.91M Jun/2026
Verastem USD 382K 33K Mar/2026